Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: A multicenter randomized trial

JAMA Surgery

Volumn 148, Issue 6, 2013, Pages 538-547

  Shi, Jia ^a   Ji, Hongwen ^a   Ren, Facheng ^b   Wang, Gang ^c   Xu, Meiying ^d   Xue, Yuliang ^e   Chen, Min ^f   Qi, Juan ^g   Li, Lihuan ^a  

^a FUWAI HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c General Hospital of Chinese People's Liberation Army   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e TEDA INTERNATIONAL CARDIOVASCULAR HOSPITAL   (China)

^f FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^g FUJIAN PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PLACEBO; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD VOLUME; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURGICAL MORTALITY; THROMBOCYTE FUNCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CORONARY ARTERY BYPASS; DRUG INTERACTIONS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TRANEXAMIC ACID; YOUNG ADULT;

EID: 84879378458     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.1560     Document Type: Article

References (23)

1. Braunwald E, Antman EM, Beasley JW, et al; American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patientswith unstable angina and non-ST-segment elevation myocardial infarction- summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40(7):1366-1374.
2. Anderson JL, Adams CD, Antman EM, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of PatientsWith Unstable Angina/Non STElevation Myocardial Infarction). developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116(7):e148-e304.
3. Kushner FG, Hand M, Smith SC Jr, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 Focused updates: ACC/AHA guidelines for the management of patients with st-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2010;121(12):e257]. Circulation. 2009;120(22):2271-2306.
4. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al; ACC/AHA/SCAI. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51(2): 172-209.
5. Stone GW, McLaurin BT, Cox DA, et al; ACUITY Investigators. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355(21):2203- 2216. (Pubitemid 44791162)
6. Ferguson JJ, Califf RM, Antman EM, et al; SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromesmanaged with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004;292(1): 45-54.
7. Brown JR, Birkmeyer NJ, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115(22):2801-2813. (Pubitemid 46876483)
8. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet. 1999;354(9194):1940-1947.
9. Soslau G, Horrow J, Brodsky I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol. 1991;38(2):113-119.
10. Weber CF, Schneider AC, Kirschning T, Hofstetter C, Zacharowski K, Görlinger K. Therapeutic options for perioperatively acquired platelet dysfunctions [in German]. Anaesthesist. 2009;58(9):931-932, 934-936, 938-940.
11. Kickler T. Alternatives to platelet transfusion in the management of platelet dysfunction or thrombocytopenia. Transfus Altern Transfus Med. 2006;8(2):127- 134. doi:10.1111/j.1778-428X.2006.00014.x.
12. Fox KA, Mehta SR, Peters R, et al; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-STelevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004;110(10):1202-1208. (Pubitemid 39202333)
13. Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg. 2003;96(4):923-928. (Pubitemid 36359017)
14. Mezzano D, Panes O, Muñoz B, et al. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Thromb Haemost. 1999;82(4):1250-1254. (Pubitemid 29473787)
15. Sabovic M, Zupan IP, Salobir B, et al. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients. Thromb Haemost. 2005;94(6):1245-1250. (Pubitemid 41819623)
16. Weber CF, Görlinger K, Byhahn C, et al. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol. 2011;28(1):57-62.
17. Amara U, Rittirsch D, Flierl M, et al. Interaction between the coagulation and complement system. Adv Exp Med Biol. 2008;632:71-79.
18. Fitch JC, Rollins S, Matis L, et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation. 1999;100(25):2499-2506. (Pubitemid 30005113)
19. van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990;99(5):788-796, discussion 796-797.
20. de Haan J, van Oeveren W. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin. Thromb Res. 1998;92(4):171-179. (Pubitemid 28541063)
21. Dowd NP, Karski JM, Cheng DC, et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology. 2002;97(2):390-399. (Pubitemid 34847752)
22. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The doseresponse relationship of tranexamic acid. Anesthesiology. 1995;82(2):383- 392.
23. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011; (1):CD001886.